Dombernowsky, P <br/><br/>
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors.  [electronic resource] 

 -  Cancer chemotherapy reports  Feb 1972 
 - 71-82 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0069-0112 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Female<br/>Glycosides--therapeutic use<br/>Haplorhini<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Immunosuppression Therapy<br/>Lactones--therapeutic use<br/>Lymphoma--drug therapy<br/>Male<br/>Mice<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Neoplasms, Experimental--drug therapy<br/>Phytotherapy<br/>Plants, Medicinal<br/>Plants, Toxic<br/>Podophyllin--toxicity<br/>Podophyllum--therapeutic use<br/>Rats<br/>Thiophenes--therapeutic use